Invivyd Inc (IVVD)

Sector:
HEALTH CARE
Industry:
PHARMACEUTICALS
SIC:
BIOLOGICAL PRODUCTS, (NO DISGNOSTIC SUBSTANCES)
CEO:
David Hering
Employees:
100
1601 TRAPELO ROAD, SUITE 178, WALTHAM, MA, 02451
(781) 819-0080

Adagio Therapeutics focuses on the discovery, development, and commercialization of antibody-based solutions for infectious diseases in the United States. The company's lead product candidate is the ADG20 (adintrevimab), a neutralizing antibody that is in Phase 3 clinical trials for the treatment and prevention of coronavirus disease.

Data derived from most recent annual or quarterly report
Market Cap 194.134 Million Shares Outstanding109.68 Million Avg 30-day Volume 246.376 Thousand
P/E Ratio0.0 Dividend Yield0.0 EPS-0.46
Price to Revenue0.0 Debt to Equity0.0 EBITDA-180.745 Million
Price to Book Value0.4082 Operating Margin0.0 Enterprise Value-183.507 Million
Current Ratio9.537 EPS Growth0 Quick Ratio9.181
1 Yr BETA 1.0956 52-week High/Low 4.09 / 0.98 Profit Margin0.0
Operating Cash Flow Growth25.3205 Free Cash Flow to Firm (FCFF) TTM -175.121 Million Free Cash Flow to Equity (FCFE) TTM-134.245 Million
Altman Z-Score-1.4879
View SEC Filings from IVVD instead.

View recent insider trading info

Invivyd Inc YCharts
Yahoo! Finance finviz
SEC Web Site SEC DEF 14A Filings

Funds Holding IVVD (via 13F filings)

Refresh Download CSV Download Excel (.xlsx) Download TSV
Filter by:
Click for Additional Filters
to
to
to
Refresh
*Shares are split adjusted
*Please note that if a filer hasn't submitted a 13F filing for a quarter then the filer's shares will be listed as "Sold All"

Mutual Funds Holding IVVD

Download CSV

Active Schedule 13D and 13G filings

Please sign in first

Recent Filings

Financial Reporting

Ownership

  • 4: filed on 2023-07-27 by COTTER SARA
  • 3: filed on 2023-07-27 by COTTER SARA
  • 4: filed on 2023-05-25 by LINDENBOOM CHRISTINE
  • 4: filed on 2023-05-25 by BERRY TAMSIN
  • 4: filed on 2023-04-12 by ALLEN ROBERT D. III
  • 3: filed on 2023-04-12 by ALLEN ROBERT D. III
  • 4: filed on 2023-03-28 by PRICE STACY
  • 3: filed on 2023-03-28 by PRICE STACY
  • 4: filed on 2022-12-16 by DABORA REBECCA
  • 4: filed on 2022-12-16 by ANDERSEN JILL

    • Events (8k)

  • 8-K: filed on 2023-09-11:
    Item 8.01: Other Events
    Item 9.01: Financial Statements and Exhibits
  • 8-K: filed on 2023-09-05:
    Item 5.02: Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers; Compensatory Arrangements of Certain Officers
    Item 7.01: Regulation FD Disclosure
    Item 9.01: Financial Statements and Exhibits
  • 8-K: filed on 2023-08-10:
    Item 2.02: Results of Operations and Financial Condition
    Item 9.01: Financial Statements and Exhibits
  • 8-K: filed on 2023-07-27:
    Item 5.02: Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers; Compensatory Arrangements of Certain Officers
    Item 7.01: Regulation FD Disclosure
    Item 9.01: Financial Statements and Exhibits
  • 8-K: filed on 2023-06-29:
    Item 8.01: Other Events
    Item 9.01: Financial Statements and Exhibits
  • 8-K: filed on 2023-05-25:
    Item 5.03: Amendments to Articles of Incorporation or Bylaws; Change in Fiscal Year
    Item 5.07: Submission of Matters to a Vote of Security Holders
    Item 9.01: Financial Statements and Exhibits
  • 8-K: filed on 2023-05-11:
    Item 2.02: Results of Operations and Financial Condition
    Item 9.01: Financial Statements and Exhibits
  • 8-K: filed on 2023-05-02:
    Item 5.02: Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers; Compensatory Arrangements of Certain Officers
    Item 8.01: Other Events
    Item 9.01: Financial Statements and Exhibits
  • 8-K: filed on 2023-03-23:
    Item 2.02: Results of Operations and Financial Condition
    Item 9.01: Financial Statements and Exhibits
  • 8-K: filed on 2023-03-06:
    Item 8.01: Other Events
    Item 9.01: Financial Statements and Exhibits

    • Proposed Sales (Form 144)

    Proxy

    Prospectus

    All

    Open Market Buys/Sells Last 60 Days

    Open Market Buys (P)

    none

    Open Market Sells (S)

    none

    Exercise Derivative Conversion (M)

    none

    Current/Former Insiders

    Insider Name Type Last Reported Shares Held Last Reported Date Filings in past year

    DUKE WILLIAM E. CHIEF FINANCIAL OFFICER

    • Officer
    		 0 2023-09-01 2

    COTTER SARA

    • Director
    		 1,000 2023-07-25 2

    MCGUIRE TERRANCE

    • Director
    		 0 2023-05-23 1

    WYZGA MICHAEL S

    • Director
    		 0 2023-05-23 1

    MEANWELL CLIVE

    • Director
    		 0 2023-05-23 1

    ELIA MARC

    M28 CAPITAL MANAGEMENT LP

    • Director
    • SEE REMARKSSEE REMARKS
    		 0 2023-05-23 1

    HEYMAN TOMAS J.

    • Director
    		 0 2023-05-23 1

    BERRY TAMSIN

    • Director
    		 0 2023-05-23 1

    LINDENBOOM CHRISTINE

    • Director
    		 0 2023-05-23 3

    ALLEN ROBERT D. III CHIEF SCIENTIFIC OFFICER

    • Officer
    		 0 2023-04-11 2

    PRICE STACY CHIEF TECH. AND MANUF. OFFICER

    • Officer
    		 0 2023-03-27 2

    GOWLER JEREMY COO & CCO

    • Officer
    		 0 2022-12-16 2

    DABORA REBECCA CHIEF TECH AND MANUF OFFICER

    • Officer
    		 100,000 2022-12-14 1

    HERING DAVID CHIEF EXECUTIVE OFFICER

    • Officer
    • Director
    		 1,600,000 2022-12-14 1

    ANDERSEN JILL CHIEF LEGAL OFFICER, SECRETARY

    • Officer
    		 300,000 2022-12-14 2

    SCHMIDT PETER CHIEF MEDICAL OFFICER

    • Officer
    		 200,000 2022-12-14 3

    DRISCOLL FREDERICK W INTERIM CFO

    • Officer
    		 0 2022-10-13 1

    MAYER HOWARD

    • Director
    		 75,000 2022-06-22 0

    MILLER REDONDA

    • Director
    		 44,178 2022-06-22 0

    MITHRIL II LP

    MITHRIL II GP LP

    MITHRIL II UGP LLC

    THIEL PETER

    • 10% Owner
    • SEE REMARKSSEE REMARKSSEE REMARKSSEE REMARKS
    		 11,241,580 2022-03-28 0

    POLARIS VENTURE PARTNERS V, L.P.

    POLARIS VENTURE PARTNERS ENTREPRENEURS' FUND V, L.P.

    POLARIS VENTURE PARTNERS FOUNDERS' FUND V, L.P.

    POLARIS VENTURE PARTNERS SPECIAL FOUNDERS' FUND V, L.P.

    POLARIS VENTURE MANAGEMENT CO. V, L.L.C.

    POLARIS PARTNERS IX, L.P.

    POLARIS PARTNERS GP IX, L.L.C.

    POLARIS HEALTHCARE TECHNOLOGY OPPORTUNITIES FUND, L.P.

    POLARIS HEALTHCARE TECHNOLOGY OPPORTUNITIES FUND GP, L.L.C.

    FLINT JONATHAN A

    • SEE REMARKSSEE REMARKSSEE REMARKSSEE REMARKSSEE REMARKSSEE REMARKSSEE REMARKSSEE REMARKSSEE REMARKSSEE REMARKS
    		 8,531,700 2022-03-28 0

    COX CHRISTOPHER T

    • SEE EXPLANATION OF RESPONSES
    		 679,822 2022-03-28 0

    COX CHRISTOPHER T

    POPULATION HEALTH EQUITY PARTNERS VII, L.P.

    POPULATION HEALTH EQUITY PARTNERS III GP, LLC

    POPULATION HEALTH EQUITY PARTNERS III, L.P.

    POPULATION HEALTH EQUITY PARTNERS VII GP, LLC

    • SEE EXPLANATION OF RESPONSESSEE EXPLANATION OF RESPONSESSEE EXPLANATION OF RESPONSESSEE EXPLANATION OF RESPONSESSEE EXPLANATION OF RESPONSES
    		 679,822 2022-03-28 0

    ROYAN AJAY

    • Director
    • 10% Owner
    • SEE REMARKS
    		 11,241,580 2022-03-28 0

    ADIMAB, LLC

    • 10% Owner
    • SEE REMARKS
    		 26,687,906 2022-03-03 0

    HENDERSON JANE CHIEF FINANCIAL OFFICER

    • Officer
    		 175,000 2022-01-30 0

    GERNGROSS TILLMAN U. CHIEF EXECUTIVE OFFICER

    • Officer
    • Director
    • 10% Owner
    		 175,000 2022-01-30 0

    HERSHBERGER ELHAM CHIEF DEVELOPMENT OFFICER

    • Officer
    		 175,000 2022-01-30 0

    CONNOLLY LYNN CHIEF MEDICAL OFFICER

    • Officer
    		 175,000 2022-01-30 0

    MARRAM ELLEN R

    • Director
    		 0 2021-11-19 0

    REDMILE GROUP, LLC

    GREEN JEREMY

    • 10% Owner
    		 3,390,960 2021-08-10 0

    SOUTHPAW ASSET MANAGEMENT LP

    SOUTHPAW HOLDINGS LLC

    WYMAN KEVIN

    GOLDEN HOWARD

    • 10% Owner
    		 835,686 2012-03-02 0

    Insider Transactions Last 60 Days

    Reporting Owners Filing Date Trans Date Trans Code Shares Share Price Acquired
    Disposed    		 Shares Owned after D/I 10b5 Perf 1d* Perf 5d* Perf 1m* Max Gain Max Gain Days Max Loss Max Loss Days

    DUKE WILLIAM E. - Officer CHIEF FINANCIAL OFFICER

    		2023-09-05 16:36:06 -0400 2023-09-01 A 750,000 a 750,000 direct

    * -

    Transaction Code Definitions
    Code Definition
    A Grant, award or other acquisition pursuant to Rule 16b-3(d)
    C Conversion of derivative security
    D Disposition to the issuer of issuer equity securities pursuant to Rule 16b-3(e)
    E Expiration of short derivative position
    F Payment of exercise price or tax liability by delivering or withholding securities incident to the receipt, exercise or vesting of a security issued in accordance with Rule 16b-3
    G Bona fide gift
    H Expiration (or cancellation) of long derivative position with value received
    I Discretionary transaction in accordance with Rule 16b-3(f) resulting in acquisition or disposition of issuer securities
    J Other acquisition or disposition
    L Small acquisition under Rule 16a-6
    M Exercise or conversion of derivative security exempted pursuant to Rule 16b-3
    O Exercise of out-of-the-money derivative security
    P Open market or private purchase of non-derivative or derivative security
    S Open market or private sale of non-derivative or derivative security
    U Disposition pursuant to a tender of shares in a change of control transaction
    W Acquisition or disposition by will or the laws of descent and distribution
    X Exercise of in-the-money or at-the-money derivative security
    Z Deposit into or withdrawal from voting trust

    IBR Securities Loan Availability

    Updated throughout the day, this shows the number of shares available to borrow. Data provided by Interactive Brokers

    Security Date/Time Rebate Rate Fee Rate Shares Available
    INVIVYD INC IVVD 2023-09-29 22:15:03 UTC -0.3059 5.6259 2500000
    INVIVYD INC IVVD 2023-09-29 21:45:04 UTC -0.3059 5.6259 2500000
    INVIVYD INC IVVD 2023-09-29 21:15:03 UTC -0.3059 5.6259 2500000
    INVIVYD INC IVVD 2023-09-29 20:45:05 UTC -0.3059 5.6259 2500000
    INVIVYD INC IVVD 2023-09-29 20:15:04 UTC -0.3059 5.6259 2500000
    INVIVYD INC IVVD 2023-09-29 19:45:04 UTC -0.3059 5.6259 2500000
    INVIVYD INC IVVD 2023-09-29 19:15:03 UTC 0.0 0.0 2500000
    INVIVYD INC IVVD 2023-09-29 18:45:03 UTC 0.0 0.0 2500000
    INVIVYD INC IVVD 2023-09-29 18:15:03 UTC 0.0 0.0 2500000
    INVIVYD INC IVVD 2023-09-29 17:45:03 UTC -0.3059 5.6259 2500000
    INVIVYD INC IVVD 2023-09-29 17:15:04 UTC -0.3059 5.6259 2500000
    INVIVYD INC IVVD 2023-09-29 16:45:04 UTC -0.3059 5.6259 2500000
    INVIVYD INC IVVD 2023-09-29 16:15:03 UTC -0.3059 5.6259 2500000
    INVIVYD INC IVVD 2023-09-29 15:45:04 UTC -0.3059 5.6259 2500000
    INVIVYD INC IVVD 2023-09-29 15:15:04 UTC -0.3059 5.6259 2500000
    INVIVYD INC IVVD 2023-09-29 14:45:04 UTC -0.3059 5.6259 2500000
    INVIVYD INC IVVD 2023-09-29 14:15:04 UTC -0.3059 5.6259 2500000
    INVIVYD INC IVVD 2023-09-29 13:45:03 UTC 1.0372 4.2828 2500000
    INVIVYD INC IVVD 2023-09-29 13:15:04 UTC 1.0372 4.2828 2500000
    INVIVYD INC IVVD 2023-09-29 12:45:05 UTC 1.0372 4.2828 2500000

    Current Active Short Positions

    Holder Issuer Net Short Position Position Date Origin
    Blackstone Alternative Investment Funds- Blackstone Alternative Multi-Strategy Fund IVVD -5200.0 shares, $-5460.0 2023-06-30 N-PORT

    No recent transactions

    *** To see all congressional transactions (since 2022) for this stock, please use the congressional transaction search page***

    WhaleWisdom Logo

    Elevate your investments